 | Up a level |
Gnarra, O; van der Meer, J; Warncke, J; Wenz, E; Fragolente, L.; Khatami, R; Schindler, K; Tzovara, A; Schmidt, M H; Bassetti, C L (2022). SPHYNCS: Longterm monitoring with Fitbit in patients with narcolepsy and its borderland. Sleep medicine, 100, S105-S106. Elsevier 10.1016/j.sleep.2022.05.294
Cam, E; Gao, B; Imbach, L; Hodor, A; Bassetti, C L (2013). Sleep deprivation before stroke is neuroprotective: A pre-ischemic conditioning related to sleep rebound. Experimental neurology, 247, pp. 673-679. San Diego, Calif.: Elsevier 10.1016/j.expneurol.2013.03.003
Leone, M A; Brainin, M; Boon, P; Pugliatti, M; Keindl, M; Bassetti, C L (2013). Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012. European journal of neurology, 20(3), pp. 410-9. Oxford: Blackwell Science 10.1111/ene.12043
Zavalko, I; Bassetti, C L; Cianfoni, A; Carugati, J; Fulda, S; Manconi, M (2012). Hypersomnia due to bilateral thalamic lesions: unexpected response to Modafinil. European journal of neurology, 19(11), e125-6. Oxford: Blackwell Science 10.1111/j.1468-1331.2012.03835.x
Hoever, P; Dorffner, G; Beneš, H; Penzel, T; Danker-Hopfe, H; Barbanoj, M J; Pillar, G; Saletu, B; Polo, O; Kunz, D; Zeitlhofer, J; Berg, S; Partinen, M; Bassetti, C L; Högl, B; Ebrahim, I O; Holsboer-Trachsler, E; Bengtsson, H; Peker, Y; Hemmeter, U-M; ... (2012). Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clinical pharmacology & therapeutics, 91(6), pp. 975-85. New York, N.Y.: Nature Publishing Group 10.1038/clpt.2011.370
Landolt, H-P; Glatzel, M; Blättler, T; Achermann, P; Roth, C; Mathis, J; Weis, J; Tobler, I; Aguzzi, A; Bassetti, C L (2006). Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology, 66(9), pp. 1418-24. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1212/01.wnl.0000210445.16135.56
